
Auteur B. KILMER
|
Documents disponibles écrits par cet auteur (40)

* Research Questions: What types of cannabis products are produced and sold in Washington State? What is the size of the cannabis market in Washington State three years after licensing cannabis production and sales for nonmedical purposes? * [...]
To learn more about the possible outcomes of marijuana legalization in California, RAND researchers constructed a model based on a series of estimates of current consumption, current and future prices, how responsive use is to price changes, tax[...]
P. H. REUTER ; F. TRAUTMANN ; R. L. PACULA ; B. KILMER ; GAGELDONK A. ; D. VAN DER GOUWE | 2009
RapportThis report provides key findings of the RAND Europe study which assesses how the global market for illicit drugs has developed from 1998 to 2007 and describes worldwide drug policies implemented during that period to address the problem. The st[...]
S. DAVENPORT ; M. ROBBINS ; M. CERDA ; A. RIVERA-AGUIRRE ; B. KILMER | 2021
Dans Addiction (Vol.116, n°5, May 2021) Article : PériodiqueBACKGROUND AND AIMS: Debates regarding lowering the blood alcohol concentration (BAC) limit for drivers are intensifying in the United States and other countries, and the World Health Organization recommends that the limit for adults should be 0[...]
B. KILMER ; J. P. CAULKINS ; G. MIDGETTE ; L. DAHLKEMPER ; R. J. MACCOUN ; R. L. PACULA | 2013
RapportIn 2012, Washington state voters passed Initiative 502 (I-502), which removed the prohibition on the production, distribution, and possession of marijuana for nonmedical purposes and required the state to regulate and tax a new marijuana industr[...]
B. KILMER ; J. P. CAULKINS ; R. L. PACULA ; P. H. REUTER | 2011
Dans Drug and Alcohol Dependence (Vol.119, n°1-2, December 2011) Article : PériodiqueHaving a sense of the scale of an illicit drug market is important for projecting consequences of alternative policy regimes. In this article, we review two general approaches to drug market estimation - supply-side and demand-side - before turn[...]
J. P. CAULKINS ; B. KILMER ; P. H. REUTER ; G. MIDGETTE | 2015
Dans Addiction (Vol.110, n°5, May 2015) Article : PériodiqueAims: Drug policy strategies and discussions often use prevalence of drug use as a primary performance indicator. However, three other indicators are at least as relevant: the number of heavy users, total expenditures and total amount consumed. [...]![]()
B. KILMER ; J. TAYLOR ; J. P. CAULKINS ; P. A. MUELLER ; A. J. OBER ; B. PARDO ; R. SMART ; L. STRANG ; P. H. REUTER | 2018
RapportCurrent levels of opioid-related morbidity and mortality in the United States are staggering. Data for 2017 indicate that there were more than 47,000 opioid-involved overdose deaths, and one in eight adults now reports having had a family member[...]
J. P. CAULKINS ; B. KILMER | 2016
Dans Addiction (Vol.111, n°12, December 2016) Article : PériodiqueBackground and Aims: In 2014 the legislature of Vermont, USA passed a law requiring the Secretary of Administration to report on the consequences of legalizing marijuana. The RAND Corporation was commissioned to write that report. This paper sum[...]
J. P. CAULKINS ; B. KILMER ; M. A. R. KLEIMAN ; R. J. MACCOUN ; G. MIDGETTE ; P. OGLESBY ; R. L. PACULA ; P. REUTER | 2015
RapportMarijuana legalization is a controversial and multifaceted issue that is now the subject of serious debate. Since 2012, four U.S. states have passed ballot initiatives to remove prohibition and legalize a for-profit commercial marijuana industry[...]
Changing patterns in drug use and supply can affect the well-being and development of Asian countries in many ways: The burden of disease from injection drug use, overreliance on the criminal justice system, and rise of drug-related crime can im[...]
J. P. CAULKINS ; B. KILMER ; R. J. MACCOUN ; R. L. PACULA ; P. REUTER | 2012
Dans Addiction (Vol.107, n°5, May 2012) Article : PériodiqueAims No modern jurisdiction has ever legalized commercial production, distribution and possession of cannabis for recreational purposes. This paper presents insights about the effect of legalization on production costs and consumption and highli[...]
R. L. PACULA ; B. KILMER ; A. C. WAGENAAR ; F. J. CHALOUPKA ; J. P. CAULKINS | 2014
Dans American Journal of Public Health (Vol.104, n°6, June 2014) Article : PériodiqueUntil November 2012, no modern jurisdiction had removed the prohibition on the commercial production, distribution, and sale of marijuana for nonmedical purposes - not even the Netherlands. Government agencies in Colorado and Washington are now [...]
Highlights [Extracts]: * Our estimates for the EU cannabis market suggest a range of approximately €7 billion to €10 billion for 2010. These estimates are likely low as they do not account for the "consumption gap" that is created when data fro[...]